Back to STOK
Lynx1 Capital Management LP → STOK
Lynx1 Capital Management LP STOK Position History
Stoke Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$101.3M
Q3 2026
Peak value
$171.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $171.5M |
| Q1 2026 | $155.1M |
| Q2 2026 | $132.1M |
| Q2 2026 | $132.1M |
| Q3 2026 | $101.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $101.3M | 3.90M | — | — |
| Q2 2026 | $132.1M | 4.04M | — | — |
| Q2 2026 | $132.1M | 4.04M | — | — |
| Q1 2026 | $155.1M | 4.76M | — | — |
| Q4 2025 | $171.5M | 5.40M | — | — |
Other funds holding STOK
$184M
$183.1M
$176.1M
$153.3M
$151M
$150.6M
$146.2M
$139.2M